SCHEMBL19264162

SCHEMBL19264162

Cc1cn(C2CCC2)c2ncnc(N)c12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 11/20 0.61
ABL1 P00519 10/20 0.61
EGFR P00533 9/20 0.61
ABL2 P42684 9/20 0.61
RET P07949 5/20 0.60
LCK P06239 2/20 0.60
CSF1R P07333 2/20 0.60
IGF1R P08069 2/20 0.60
FGFR1 P11362 2/20 0.60
FLT1 P17948 2/20 0.60
KDR P35968 2/20 0.60
FLT3 P36888 2/20 0.60
MST1R Q04912 2/20 0.60
NTRK3 Q16288 2/20 0.60
NTRK2 Q16620 2/20 0.60
ALK Q9UM73 2/20 0.60
DAPK3 O43293 1/20 0.60
MAP4K4 O95819 1/20 0.60
PAK4 O96013 1/20 0.60
FYN P06241 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24072104 0.94 RIPK2 (0.61) SRCABL1EGFRABL2RET
SCHEMBL14644244 0.87 RIPK2 (0.52) SRCABL1EGFRABL2RET
SCHEMBL10261381 0.87 FGR (0.57) SRCABL1EGFRABL2RET
SCHEMBL24651203 0.85 ABL1 (0.49) SRCABL1EGFRABL2RET
SCHEMBL14643787 0.84 ADK (0.52) SRCABL1EGFRABL2RET
SCHEMBL19563041 0.84 ADK (0.55) SRCABL1EGFRABL2RET
SCHEMBL14643106 0.84 ADK (0.52) SRCABL1EGFRABL2RET
SCHEMBL10261916 0.84 ADK (0.55) SRCABL1EGFRABL2RET
SCHEMBL24251908 0.82 ADK (0.48) SRCABL1EGFRABL2RET
SCHEMBL19264034 0.82 ADK (0.53) SRCABL1EGFRABL2RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021242505-A1 INHIBITORS OF NEK7 KINASE Halia Therapeutics, Inc. (US) 2021-12-02 WO disclosed
WO-2021155004-A1 STRAD-BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-05 WO disclosed
EP-2168968-B1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors OSI PHARMACEUTICALS LLC (US) 2017-08-23 EP disclosed